Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9144703rdf:typepubmed:Citationlld:pubmed
pubmed-article:9144703lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:9144703lifeskim:mentionsumls-concept:C0337527lld:lifeskim
pubmed-article:9144703lifeskim:mentionsumls-concept:C0006845lld:lifeskim
pubmed-article:9144703lifeskim:mentionsumls-concept:C0064113lld:lifeskim
pubmed-article:9144703pubmed:issue2lld:pubmed
pubmed-article:9144703pubmed:dateCreated1997-7-15lld:pubmed
pubmed-article:9144703pubmed:abstractTextWe report on two children affected by chronic mucocutaneous candidiasis involving the mouth and all the nails who were successfully treated with itraconazole at 200 mg/day for 2 months. This therapy produced a rapid cure of both candidal nail and mouth infections. The drug was very well tolerated, and routine laboratory monitoring during treatment did not reveal any abnormalities.lld:pubmed
pubmed-article:9144703pubmed:languageenglld:pubmed
pubmed-article:9144703pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9144703pubmed:citationSubsetIMlld:pubmed
pubmed-article:9144703pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9144703pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9144703pubmed:statusMEDLINElld:pubmed
pubmed-article:9144703pubmed:issn0736-8046lld:pubmed
pubmed-article:9144703pubmed:authorpubmed-author:TostiAAlld:pubmed
pubmed-article:9144703pubmed:authorpubmed-author:PiracciniB...lld:pubmed
pubmed-article:9144703pubmed:authorpubmed-author:VincenziCClld:pubmed
pubmed-article:9144703pubmed:authorpubmed-author:CameliNNlld:pubmed
pubmed-article:9144703pubmed:issnTypePrintlld:pubmed
pubmed-article:9144703pubmed:volume14lld:pubmed
pubmed-article:9144703pubmed:ownerNLMlld:pubmed
pubmed-article:9144703pubmed:authorsCompleteYlld:pubmed
pubmed-article:9144703pubmed:pagination146-8lld:pubmed
pubmed-article:9144703pubmed:dateRevised2009-3-3lld:pubmed
pubmed-article:9144703pubmed:meshHeadingpubmed-meshheading:9144703-...lld:pubmed
pubmed-article:9144703pubmed:meshHeadingpubmed-meshheading:9144703-...lld:pubmed
pubmed-article:9144703pubmed:meshHeadingpubmed-meshheading:9144703-...lld:pubmed
pubmed-article:9144703pubmed:meshHeadingpubmed-meshheading:9144703-...lld:pubmed
pubmed-article:9144703pubmed:meshHeadingpubmed-meshheading:9144703-...lld:pubmed
pubmed-article:9144703pubmed:meshHeadingpubmed-meshheading:9144703-...lld:pubmed
pubmed-article:9144703pubmed:meshHeadingpubmed-meshheading:9144703-...lld:pubmed
pubmed-article:9144703pubmed:meshHeadingpubmed-meshheading:9144703-...lld:pubmed
pubmed-article:9144703pubmed:meshHeadingpubmed-meshheading:9144703-...lld:pubmed
pubmed-article:9144703pubmed:articleTitleItraconazole in the treatment of two young brothers with chronic mucocutaneous candidiasis.lld:pubmed
pubmed-article:9144703pubmed:affiliationDepartment of Dermatology, University of Bologna, Italy.lld:pubmed
pubmed-article:9144703pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9144703pubmed:publicationTypeCase Reportslld:pubmed